to two new-generation COVID-19 mRNA vaccines from Pfizer/BioNTech and Moderna, both targeting the new Omicron subvariants BA.4 and BA.5. The US regulator has cleared a 30 µg booster dose of a new ...

Some expert groups, including the Joint Committee on Vaccination and Immunisation (JCVI) in the UK, have recommended that a single dose of ... hope of our Omicron-containing bivalent booster ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

However, BioNTech continues to innovate, with an omicron-targeting bivalent vaccine launched in 2022 and a new XBB-targeting monovalent vaccine launched in September 2023, as well as ongoing ...

The Federal Government has taken delivery of one million doses of the R21/Matrix-M malaria vaccine donated by Gavi, the Vaccine Alliance. The hand-over ceremony took place on Thursday in Abuja.

Approximately 1,000 additional doses of our investigational #Marburg vaccine are on their way to #Rwanda to support a new randomized clinical trial arm under an existing open-label study. With ...

Last month the Centers for Disease Control and Prevention reported that childhood vaccination rates dipped ... getting 95% of kids immunized with two doses of the measles, mumps and rubella ...

Those complaints are searchable, including by the public, but they aren’t vetted, and reports may have nothing at all to do with a vaccine dose. The searchable data is also nonspecific.

New research shows that vaccines that target multiple strains of the RSV virus, called bivalent vaccines, may provide longer protection. URMC infectious disease experts Edward Walsh, MD ...